HELSINN BIREX PHARMACEUTICALS LIMITED

GELCLAIR

Pharmaceutical preparations for the treatment of ulcerative and inflammatory conditions;GEL CLAIR;

LEDAGA

Pharmaceutical preparations for the treatment of cardiovascular and pulmonary diseases, inflammatory diseases, cancer, auto-immune disorders, digital ulcers, glycolipid storage diseases, cerebrovascular diseases, diseases and disorders of the central nervous system and of the peripheral neurological system, neurodegenerative diseases and disorders, gastrointestinal disorders, anxiolytics, anti-allergics, anti-infectives;The wording LEDAGA has no meaning in a foreign language.;

VALCHLOR

In the statement, Column 1, line 6, vitiligo, psoriasis, and alopecia areata is deleted.;pharmaceutical preparations for the treatment of lymphomas, non-Hodgkins lymphomas, cutaneous T cell lymphomas, mycosis fungoides [, vitiligo, psoriasis, and alopecia areata ];

VALCHLOR SUPPORT

[ Publications, namely, newsletters, reports, brochures, and printed teaching materials in the fields of healthcare and pharmaceuticals ] * ((downloadable brochures in the fields of healthcare and pharmaceuticals)) *;In the statement, line 4 and 5, is deleted, and downloadable brochures in the fields of healthcare and pharmaceuticals is inserted; Class 16 is reclassified to Class 9;Providing insurance information to patients and healthcare professionals; providing financial information about health benefit plans to patients and healthcare professionals;Providing healthcare information about the treatment of lymphomas and fungoides; providing a website featuring medical information and information relating to the therapeutic properties of pharmaceuticals for patient management, monitoring and care;SUPPORT IN INTERNATIONAL CLASSES 036 AND 044;